REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Oxigenos del Sur S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Oxigenos del Sur S.A.S. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Oxigenos del Sur S.A.S. is a company in Colombia, with a head office in Palmira. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. Oxigenos del Sur S.A.S. was incorporated on September 06, 2001. In 2024, the company reported a net sales revenue increase of 1.08%. A growth of 7.8% was recorded in its total assets. In, 2024, the company’s net profit margin increased by 0.13%.

Headquarters
Cra 28 37A 40
Palmira; Valle del Cauca;

Contact Details: Purchase the Oxigenos del Sur S.A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the Oxigenos del Sur S.A.S. report to view the information.
Financial Auditors:
Purchase the Oxigenos del Sur S.A.S. report to view the information.
Incorporation Date:
September 06, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Oxigenos del Sur S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
1.08%▲
Total operating revenue
1.92%▲
Operating profit (EBIT)
2.53%▲
EBITDA
2.53%▲
Net Profit (Loss) for the Period
2.17%▲
Total assets
7.8%▲
Total equity
14.8%▲
Operating Profit Margin (ROS)
0.31%▲
Net Profit Margin
0.13%▲
Return on Equity (ROE)
-2.15%▼
Debt to Equity Ratio
-2.53%▼
Quick Ratio
0.94%▲
Cash Ratio
0.13%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo